VAP Test Measures Cholesterol Profile


February 12, 2009

Atherotech Inc. is a cardio-diagnostic laboratory focusing on cardiovascular tests to better assess both risk and management and prevention of cardiovascular disease. The company’s patented VAP technology directly measures all lipoproteins and their subclasses. The company said the VAP Test is the first cholesterol profile to comply with updated NCEP ATP III recommendations for LDL measurement and is the only advanced lipid profile that routinely reports all three lipoprotein parameters considered necessary by the ADA and ACC expert consensus guidelines for cardio-metabolic patients. The VAP Cholesterol Test is available through national and regional laboratories and is reimbursed by most private insurers as well as Medicare.

For more information: